National Institutes of Health
Locations
Transplant Summary
Overview
This NIH Clinical Center program supports innovative transplant approaches conducted by three NIH Institutes (NCI, NIAID, and NHLBI). To undergo a transplant, patients must be enrolled in an active clinical trial at one of these institutes.This center has been performing allogeneic transplants since 1992 and has been an NMDP transplant center since March 2007.
Attending physicians
Adult - Daisuke Araki, George Aue, Richard Childs, Stefan Cordes, Ajoy Dias, Dimana Dimitrova, Stacy Doran, Emma Groarke, Dennis Hickstein, Matthew Hsieh, Jamie Hur, Mustafa Hyder, Kazusa Ishii, Courtney (Fitzhugh) Joseph, Jennifer Kanakry, Christopher Kanakry, Elizabeth Kang, Andre LaRochelle, Bisi Lawal, Vid Leko, Harry Malech, Alain Mina, Scott Norberg, Bhavisha Patel, Steven Pavletic, Christopher Pleyer, Kamil Rechache, Nirali Shah, John Tisdale
Pediatric - Danielle Arnold, Lea Cunningham, Dimana Dimitrova, Corina Gonzalez, Courtney (Fitzhugh) Joseph, Jason Levine, Emily Limerick, Lisa McReynolds, Sung-Yun Pai, Hari Sankaran, Nirali Shah, David YoungTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Transplants are provided free of charge to patients who are all enrolled in clinical trials at NIH. Funding is provided by the Federal Government.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 198 patients.The actual 1-year survival of these patients is 73.2%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 69.9% and 81.1%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
137
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow42PBSC40Cord blood0Total82Unrelated donorMarrow11PBSC43Cord blood1Total55Total allogeneicMarrow53PBSC83Cord blood1Total137AutologousMarrowBoth marrow & PBSC 0PBSC—Cord blood—Total0Total combinedMarrowBoth marrow & PBSC 136PBSC—Cord blood1Total137Total pediatric transplants
30
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow9PBSC6Cord blood0Total15Unrelated donorMarrow5PBSC5Cord blood5Total15Total allogeneicMarrow14PBSC11Cord blood5Total30AutologousMarrowBoth marrow & PBSC 0PBSC—Cord blood—Total0Total combinedMarrowBoth marrow & PBSC 25PBSC—Cord blood5Total30All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181719-445545-642065+5Total97Unrelated 0-181619-443745-641365+4Total70Autologous 0-18019-44045-64065+0Total0Total 0-183319-449245-643365+9Total167Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
National Heart Lung and Blood Institute
10 Center Drive Bethesda, MD 20814 Phone:301-480-9504 Email:colekr@mail.nih.gov Overview
The NIH Transplant and Cell Therapy Program provides care to both adult and pediatric patients post-transplant/cell therapy. The care consists of a multidisciplinary team that provides comprehensive follow-up visits. Specialists educate patients and family about the long-term effects of cancer treatment, fertility issues, adjusting to life post-transplant and more. Additionally, NIH providers continue to follow and provide resources as patients transition to local health care providers.
Staff
Program Director:Sung-Yun Pai, MDProgram Coordinator:Kristen Cole, RNMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, telemedicine, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults (over age )
- Will provide care to adult patients who underwent transplant as a child
- Does not accept patients who were transplanted at another hospital